How Hormones Change Women’s Hearts and Why Cardiology Wasn’t Built to See It

How Hormones Change Women’s Hearts and Why Cardiology Wasn’t Built to See It

Author: by FemmeHealth Alliance January 15, 2026 Duration: 27:59

In this episode of Blindspot Capital, Maryann Selfe speaks with Professor Carolin Lerchenmüller, cardiologist, clinician-scientist, and Switzerland’s first Chair of Gender Medicine, about why heart disease presents differently in women and how hormones across pregnancy, perimenopause, and menopause fundamentally reshape cardiovascular risk.

Drawing on decades of research spanning molecular cardiology and clinical care, Carolin explains why modern cardiology guidelines failed to account for female biology and what gender-informed, hormone-literate cardiology must look like next.

We Cover:

How pregnancy, perimenopause, and menopause alter cardiovascular symptoms and risk in women

Why preeclampsia and gestational hypertension are early predictors of lifetime cardiovascular disease

How declining estrogen levels affect blood vessels, cholesterol metabolism, and plaque formation

Why cardiovascular disease remains the leading cause of death in women worldwide and why awareness remains dangerously low

What a hormone-literate, gender-informed cardiology system would require in research, diagnostics, and care delivery

Carolin’s predictions for the future of gender medicine and why she sees a turning point in science and clinical practice

Links

 Learn more about the Women’s Heart Health Program at University Hospital ZurichFollow Professor Lerchenmüller on LinkedIn

And share this episode. With a founder. With a policymaker. With a friend. Because this blind spot doesn’t fix itself.

Join 10,000+ readers of the FemmeHealth newsletter on Substack.

--------------------------

📌 Watch full episode on YouTube



Get full access to The Billion Dollar Blindspot at blog.billiondollarblindspot.com/subscribe

There's a vast, often overlooked frontier in business and innovation, and Blindspot Capital is mapping its terrain. This podcast digs into the ideas, trends, and tangible investment potential shaping the future of women's health, a sector that has historically been underfunded and underserved. Each episode moves beyond surface-level discussions to examine the systemic gaps and the consequential opportunities they create. You'll hear from founders, investors, researchers, and thinkers who are actively building and funding solutions in this space, sharing their on-the-ground experiences and hard-won insights. The conversations are grounded in the reality of entrepreneurship and market dynamics, exploring not just the "why" but the "how"-how new technologies are being applied, how businesses are scaling, and how capital can be deployed to generate both impact and returns. Tune in for a clear-eyed look at an area ripe for transformation, where understanding the blind spot isn't just about awareness, but about seeing a path forward for savvy builders and backers alike. This isn't a niche side conversation; it's a central dialogue about the next wave of growth in healthcare and technology, delivered through a podcast dedicated to substantive, forward-thinking analysis.
Author: Language: English Episodes: 18

Blindspot Capital
Podcast Episodes
The Menopause Information Crisis [not-audio_url] [/not-audio_url]

Duration: 31:16
Some markets follow a familiar script: a need emerges, founders respond, capital flows, and eventually, the sector matures. But women’s health doesn’t work like that.In a recent episode of Blindspot Capital, I sat down w…
Building FemTech Infrastructure in Asia [not-audio_url] [/not-audio_url]

Duration: 39:33
Some markets follow this script: A need appears. Entrepreneurs respond. Capital flows in. Eventually, the sector matures and innovation accelerates. But some markets don’t follow that script.In a recent episode of Blinds…
Why It Takes Years to Build in Women’s Health [not-audio_url] [/not-audio_url]

Duration: 34:44
Most innovation stories are told as clean upward lines. A founder has an idea. Investors come in. The product launches. Growth follows. Eventually there is an acquisition or an IPO, and the story looks inevitable in hind…
Why Women’s Heart Disease Is Still Misdiagnosed [not-audio_url] [/not-audio_url]

Duration: 34:58
In this episode of Blindspot Capital, Maryann sits down with Professor Angela Maas (cardiologist and pioneer of sex- and gender-specific cardiology) to unpack why women’s heart disease is still misunderstood and what med…
Tough Love for Women’s Health Founders [not-audio_url] [/not-audio_url]

Duration: 26:51
In this episode of Blindspot Capital, Maryann sits down with Lisa Suennen - longtime healthcare investor, founder of the Venture Valkyrie blog, and Managing Partner of the Go Red for Women Venture Fund to unpack one of t…
The Silent Ban: How Social Media Is Censoring Women’s Health [not-audio_url] [/not-audio_url]

Duration: 25:58
In this episode of Blindspot Capital, Maryann sits down with Anna O’Sullivan, co-founder of censhership.co.uk and FutureFemHealth, to unpack a deeply underrecognized systemic bias: the routine censorship of women’s healt…
Why Most Digital Health Startups Will Fail [not-audio_url] [/not-audio_url]

Duration: 30:18
Half the headlines in healthcare are hype. But what if we stopped chasing the next shiny thing and started fixing the fundamentals?In this episode of Blindspot Capital, I sit down with Sergei Polevikov, mathematician, in…
What Real Science in Women’s Health Looks Like [not-audio_url] [/not-audio_url]

Duration: 25:15
Half the population experiences these conditions. Many are universal, recurring, and clinically significant. Yet in the eyes of too many investors, women’s health therapeutics remain “optional.”In this episode of Blindsp…